Medication info

Neodeca Injection

Prescription medicationInjections
Ingredient · strength
L-Isoleucine›0.8g / 100mLL-Leucine›1.4g / 100mLL-Methionine›0.39g / 100mLL-Phenylalanine›0.7g / 100mLL-Threonine›0.57g / 100mLL-Proline›0.5g / 100mLGlycine›0.59g / 100mLL-Lysine Acetate›1.48g / 100mLL-Tryptophan›0.2g / 100mLL-Valine›0.8g / 100mLL-Arginine›1.05g / 100mLL-Histidine›0.5g / 100mLL-Alanine›0.8g / 100mLL-Tyrosine›0.05g / 100mLL-Serine›0.3g / 100mLL-Aspartic Acid›0.1g / 100mLL-Glutamic Acid›0.1g / 100mLL-Cysteine›0.1g / 100mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
A transparent solution that is colorless or pale yellow, contained in a colorless transparent glass bottle for injection.
Packaging
200 milliliters/bottle, 250 milliliters/bottle
Approval status
Active

MFDS item code 202200709 · Approved 2022.02.15

Summary

Main use
Improvement of nutritional status through amino acid supplementation (e.g., in hypoproteinemia and malnutrition)
Who uses it
Adults · Children
Adult dosage
<Central venous administration> • Adults: Usually, 400 ~ 800mL per day (equivalent to 40 ~ 80 g of total amino acids) is administered by continuous infusion into a central vein according to the hyperalimentation method. Adjust the dose according to age, symptoms, and body weight. <Peripheral venous administration> • Adults: Slowly administer 200 ~ 400mL per dose (equivalent to 20 ~ 40 g of total amino acids) by intravenous infusion. • Infusion rate: A concentration of approximately 10g of total amino acids over 60 minutes is preferred. Usually, allow approximately 60 minutes per 100mL in adults. Adjust the dose according to age, symptoms, and body weight. Administer this medicine together with glucose or another source that provides adequate calories for parenteral nutrition.
Children's dosage
In children, administer at a reduced infusion rate.

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of nutritional status through amino acid supplementation (e.g., in hypoproteinemia and malnutrition)

  • Hypoproteinemia
  • undernutrition
View approved original text

Amino acid supply is used for hypoproteinemia, undernutrition, and recovery periods before and after surgery.

Dosage and Administration

Adult dosage

<Central venous administration> • Adults: Usually, 400 ~ 800mL per day (equivalent to 40 ~ 80 g of total amino acids) is administered by continuous infusion into a central vein according to the hyperalimentation method. Adjust the dose according to age, symptoms, and body weight. <Peripheral venous administration> • Adults: Slowly administer 200 ~ 400mL per dose (equivalent to 20 ~ 40 g of total amino acids) by intravenous infusion. • Infusion rate: A concentration of approximately 10g of total amino acids over 60 minutes is preferred. Usually, allow approximately 60 minutes per 100mL in adults. Adjust the dose according to age, symptoms, and body weight. Administer this medicine together with glucose or another source that provides adequate calories for parenteral nutrition.

Children's dosage

In children, administer at a reduced infusion rate.

Precautions

This drug must be used under the direction of a physician. Patients with allergies to the components of this drug, severe hepatic disease, severe renal impairment, or certain metabolic disorders should not use it. Patients with cardiac or pulmonary problems or fluid overload should not be given this drug. Patients with dehydration or electrolyte imbalance must receive appropriate treatment before administration and use this drug cautiously. Patients with impaired liver or kidney function require dosage adjustment and regular monitoring of liver function and ammonia levels. Patients with asthma or those sensitive to sulfites should be cautious as allergic reactions or asthma attacks may occur. When using this drug, side effects such as rash, nausea, vomiting, chest pain, and elevated liver enzymes may occur, so consult a physician immediately if abnormal symptoms appear. In patients with severe renal impairment or hypernitrogenemia, the decision to administer the drug should be made carefully depending on the method of dialysis and condition. Regular blood tests and monitoring of fluid status are important, and it is essential to administer this drug with an appropriate energy source for protein synthesis. When used with glucose, blood sugar levels should be monitored periodically, and peripheral venous injections may cause venous irritation. This drug may promote folic acid deficiency, so folic acid should be administered daily alongside it. Women who are pregnant or breastfeeding have not established the safety of this drug, so it should only be used when the therapeutic benefits outweigh the risks. Safety in children has not been adequately established, so caution is needed. Elderly patients may have reduced physical function, so care should be taken to slow the infusion rate and reduce the dose. In cases of overdose, symptoms such as increased blood volume, electrolyte imbalances, and acidosis may occur, so administration should be stopped immediately if symptoms appear. To reduce the risk of infection, maintain strict aseptic conditions before administration, use the drug immediately after opening, and do not use any remaining drug. During administration, monitor electrolyte balance, administer slowly intravenously, and if vascular pain occurs, change the injection site or stop administration. Store in a sealed container to prevent air ingress, and store at room temperature between 1 to 30 degrees Celsius for safe preservation of the drug's efficacy.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest pain
  • palpitations
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • increased total bilirubin
  • elevated BUN
  • acidosis
Show 5 more
  • chills
  • fever
  • warmth
  • headache
  • vasculitis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent air from entering, and it is safe to store at room temperature between 1 and 30 degrees Celsius. This storage method will help maintain the drug's efficacy.

Appearance and packaging

Appearance

A transparent solution that is colorless or pale yellow, contained in a colorless transparent glass bottle for injection.

Package unit

200 milliliters/bottle, 250 milliliters/bottle

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.